HomeTrading IdeasUS Dollar Softens Amidst...

US Dollar Softens Amidst Cautious Risk-On Reaction

  • Israel-Iran confrontation intensifies
  • Risk appetite improves after an abysmal session on Friday
  • Dollar is on the back foot again; both gold and oil surrender gains
  • Four central bank meetings this week, starting with BoJ on Tuesday

Israel-Iran Clash Continues

After nearly 3.5 months of tariff-driven markets, with US President Trump’s shenanigans producing a plethora of risk-off episodes, investors seem to have bigger fish to fry now. They are anxiously watching developments in the Middle East, where Friday’s initial Israeli operation on Iranian soil has triggered a tit-for-tat situation, like a boxing match, with both nations now exchanging missile attacks on a daily basis.

These types of skirmishes have become more frequent since the October 2023 events, when a Hamas-led attack on Israel set off the ongoing conflict in Gaza. Usually, there is a brief cycle of back-and-forth between Israel and Iran – including Iran’s proxies – before the West intervenes, with the situation quieting down for a while. Should this be repeated this time as well, market reaction could follow a familiar historical pattern.

However, there is a feeling that the situation might evolve differently this time around. Rhetoric from Israeli officials and the targeting of Iran’s oil and gas infrastructure and facilities – the world’s largest field, oil refineries, and fuel depots have already been hit – could be seen as an Israeli attempt for a regime change in Iran.

Meanwhile, European leaders are pushing for a ceasefire, but it might be too early for both Israel and Iran to discuss such an option. Interestingly, there is a G7 meeting taking place in Canada on June 15-17. There will probably be extensive talks about the Middle East events and tariffs. Notably, markets still remember the famous “Trump vs. everyone” photograph from the 2018 summit.

Initial Risk-Off Reaction Fades

Given the ’s newly found risk-on behaviour, the greenback got an unexpected boost on Friday, outperforming the remaining key currencies. These gains were not enough, though, to reverse the dollar’s earlier weak performance, with closing the week up 1.4%, followed by a 1.3% selloff in .

Friday’s risk-off sentiment was also quite evident in equities, with US stock indices experiencing their weakest daily session since May 21, when a disappointing auction pushed yields higher, adding to concerns that Trump’s proposed budget bill might fail to address the ballooning US debt. Notably, US equity indices managed to outperform their European counterparts last week, as the suffered its deepest losses since the first week of April.

On the flip side, both and jumped on news of escalating tensions in the Middle East, with the latter quickly climbing and reaching a fresh five-month high.

Risk appetite appears to be improving slightly today, with the dollar losing a bit of ground, both oil and gold surrendering a decent portion of their recent gains, and climbing to the $106k area again. However, this risk-on reaction could quickly reverse, especially if Iran openly threatens to block the Hormuz Straits.

Central Bankers Face Another Hurdle

These developments have come amidst one of the most important weeks in 2025. Four central banks will hold their rate-setting meetings this week, with the BoJ kicking things off on Tuesday and the announcing its decision on Wednesday. The FOMC’s position up to now has been to wait for the tariff dust to settle before making monetary policy decisions.

However, the Fed’s job has just become even harder, as the Middle East events could unsettle the rates outlook, creating a real headache if oil prices keep rising. Economic Calendar

Most Popular

More from Author

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline...

Read Now

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:) is taking a hit after Musk announced plans to launch a political party.US Futures 0.78% at 44839 0.7% at 6266 0.53% at 23977In...

Why Is Apogee Therapeutics Stock Soaring On Monday? – Apogee Therapeutics (NASDAQ:APGE)

Apogee Therapeutics Inc. APGE stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.This substantial increase in stock price follows the release of positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody, for moderate-to-severe...

EUR/USD Slips as Trade Talks Stall and Retail Sales Disappoint

falls with trade talks in focus and following weak retail sales. Oil slips after OPEC+ increases output by more than expected.EUR/USD Falls With Trade Talks in Focus and After Weak Retail SalesThe EU and the US are nearing a framework agreement Eurozone retail sales fell -0.7% MoM EUR/USD...

Oil Prices Expected to Stay Under $70

Analysts widely expect oil prices to remain below $70 per barrel for the remainder of 2025, primarily due to global oversupply and ongoing uncertainties regarding demand. Despite heightened geopolitical tensions in the Middle East, these factors are not anticipated to significantly drive up oil prices unless direct supply...